Towarzystwo Funduszy Inwestycyjnych PZU SA’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$53K Buy
250
+100
+67% +$19.6K 0.01% 456
2026
Q1
$29.4K Hold
150
0.01% 543
2025
Q4
$26K Hold
150
0.01% 581
2025
Q3
$28.6K Hold
150
0.01% 538
2025
Q2
$26.9K Hold
150
0.01% 537
2025
Q1
$25.4K Buy
+150
New +$24.6K 0.01% 533

Other funds holding DGX

Towarzystwo Funduszy Inwestycyjnych PZU SA's DGX Position: Q2 2026 in Review

Towarzystwo Funduszy Inwestycyjnych PZU SA increased its Quest Diagnostics (DGX) stake by 67% in Q2 2026, buying an estimated $19.6K and bringing the position to 250 shares worth $53K. The position accounts for 0.01% of the portfolio, ranked #456.

Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in DGX in Q1 2025 and has held it in 6 quarters since. 1,100 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Towarzystwo Funduszy Inwestycyjnych PZU SA held 250 shares of Quest Diagnostics worth $53K as of Q2 2026.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA bought 100 Quest Diagnostics shares in Q2 2026, an estimated $19.6K.
  • Quest Diagnostics made up 0.01% of Towarzystwo Funduszy Inwestycyjnych PZU SA's portfolio in Q2 2026, its #456 holding.
  • Towarzystwo Funduszy Inwestycyjnych PZU SA first reported a position in Quest Diagnostics in Q1 2025 and has held it in 6 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Towarzystwo Funduszy Inwestycyjnych PZU SA's 13F filing for Q2 2026, filed 7 Aug 2026.